| Lista de correo. Espere su aprobación. |
| Consultar este grupo |
viernes, 16 de octubre de 2015
NSF/ANSI Standard 49 Certification Testing of Biosafety Cabinets
REFERENCE:
Maren H. Roush and Stephen C. Williams. NSF/ANSI Standard 49 Certification Testing of Biosafety Cabinets. JALA 2009;14:171–3
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
viernes, 10 de octubre de 2014
Contact tracing during an #ebola outbreak
This document provides guidance for establishing and conducting contact tracing during filovirus disease outbreaks. The guidance notes are based on extensive field experience in filovirus disease outbreak response in the WHO African region. The notes are intended for frontline epidemiologists, surveillance officers, health workers and other volunteers involved in contact tracing. National and sub-national emergency management committees and rapid response teams require these guidelines to plan, implement and monitor contact tracing.National emergency management committees are advised to adapt these guidance notes to the local context in their application
REFERENCES:
Contact tracing during an #ebola outbreak
CDC poster: What is contact tracing?
Australasian Contract Tracing Manual
Development of a risk assessment tool for contact tracing people after contact with infectious patients while travelling by bus or other public ground transport: a Delphi consensus approach
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
jueves, 9 de octubre de 2014
Detailed Hospital Checklist for #Ebola Preparedness
![]() |
| Lohud.com |
In order to enhance our collective preparedness and response efforts, this checklist highlights key areas for hospital staff -- especially hospital emergency management officers, infection control practitioners, and clinical practitioners -- to review in preparation for a person with Ebola arriving at a hospital for medical care. The checklist provides practical and specific suggestions to ensure your hospital is able to detect possible Ebola cases, protect your employees, and respond appropriately.
While we are not aware of any domestic Ebola cases, now is the time to prepare, as it is possible that individuals with Ebola in West Africa may travel to your city, exhibit signs and symptoms of Ebola, and present to facilities.
REFERENCES:
- CDC Detailed Hospital Checklist for Ebola Preparedness
- Ebola infection control. WHO guideline
- AIDE-MEMOIRE. For infection prevention and control in a health care facility
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
jueves, 25 de septiembre de 2014
Addressing climate change in healthcare settings
![]() |
| Publication details Number of pages: 28 Publication date: 2009 Languages: English |
This discussion draft is based on the World Health Organization’s (WHO) mandate from member states to develop “programmes for health systems that will contribute to reducing their own greenhouse gas emissions”. It also takes root in Health Care Without Harm’s (HCWH) more than 12 years of experience of working globally to transform the health sector so that it is no longer a source of harm to human health and the environment.
World Health Organization and Health Care Without Harm. Healthy hospitals, healthy planet, healthy people: Addressing climate change in healthcare settings, 2009.
------------------------------------------------
Sigue este Blog en Facebook y Twitter
lunes, 22 de septiembre de 2014
The durability of examination gloves used on intensive care units
Methods: A total number of 1500 consecutively used pairs of examination gloves of two different brands and materials (latex and nitrile) were collected over a period of two months on two ICU’s. Used gloves were examined for micro perforations using the “water-proof-test” according to EN 455–1. Cox-regression for both glove types was used to estimate optimal changing intervals.
Results: Only 26% of gloves were worn longer than 15 min. The total perforation rate was 10.3% with significant differences and deterioration of integrity of gloves between brands (p<0.001). Apart from the brand, “change of wound dressing” (p = 0.049) and “washing patients” (p = 0.001) were also significantly associated with an increased risk of perforation.
Conclusion: Medical gloves show marked differences in their durability that cannot be predicted based on the technical data routinely provided by the manufacturer. Based on the increase of micro perforations over time and the wearing behavior, recommendations for maximum wearing time of gloves should be given. Changing of gloves after 15 min could be a good compromise between feasibility and safety. HCWs should be aware of the benefits and limitations of medical gloves. To improve personal hygiene hand disinfection should be further encouraged.
Keywords: Hand hygiene, Examination gloves, Micro perforation, Glove change, Intensive care unit, Disinfection, Multi-barrier strategy
REFERENCE:
Hübner NO, et al. The durability of examination gloves used on intensive care units. BMC Infect Dis. 2013; 13: 226.
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
miércoles, 3 de septiembre de 2014
Reducing Needle Stick Injuries in Healthcare Occupations
![]() |
| oasisdiscussions.ca |
REFERENCE:
Yang L, Mullan B. Reducing needle stick injuries in healthcare occupations: an integrative review of the literature. ISRN Nurs. 2011;2011:315432.
-------------------------------------------------
Sigue este Blog en Facebook y Twitter
martes, 2 de septiembre de 2014
Infection Control During Filoviral Hemorrhagic Fever Outbreaks #Ebola
- Raabea VN, Borcherta M. Infection control during filoviral hemorrhagic Fever outbreaks. J Glob Infect Dis. 2012 Jan;4(1):69-74.
- CDC Interim Guidance for Environmental Infection Control in Hospitals for Ebola Virus
- WHO Interim Infection Prevention and Control Guidance for Care of Patients with Suspected or Confirmed Filovirus Haemorrhagic Fever in Health-Care Settings, with Focus on Ebola => DESCARGA OPCIONAL
- Health Canada. Interim Biosafety Guidelines for Laboratories Handling Specimens from Patients Under Investigation for Ebola Virus Disease
Sigue este Blog en Facebook y Twitter
miércoles, 13 de agosto de 2014
Barriers to rapid containment of the #Ebola outbreak
El virus del Ebola es uno de los patógenos más virulentos. El equipo de protección personal es esencial, pero escasea. Además es caliente e incómodo, y limita mucho el número de horas que el personal médico y de enfermería puede trabajar en una planta de aislamiento. Según las estimaciones actuales, un centro en el que se estén tratando 70 pacientes necesitará como mínimo 250 profesionales sanitarios.
Ahora que el brote ha cumplido 6 meses, se comprueba que el miedo es el obstáculo más difícil de vencer. El miedo hace que los contactos de los casos escapen al sistema de vigilancia, que las familias escondan a los parientes con síntomas o los lleven a curanderos tradicionales, y que los pacientes huyan de los centros terapéuticos. El miedo y la hostilidad que este puede alimentar han puesto en peligro la seguridad de los equipos de respuesta nacionales e internacionales.
El personal sanitario teme por sus vidas. Hasta la fecha se han infectado más de 170 profesionales sanitarios y al menos 81 han fallecido.
-----------------------------------------------------------
jueves, 7 de agosto de 2014
Evaluation of transmission risks associated with in vivo replication of several high containment pathogens in a biosafety level 4 laboratory #EBOLA
REFERENCE:
Alimonti J, et al. Evaluation of transmission risks associated with in vivo replication of several high containment pathogens in a biosafety level 4 laboratory. Scientific Reports 4, Article number: 5824.
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
miércoles, 6 de agosto de 2014
Transmission of #Ebola virus from pigs to non-human primates
REFERENCE:
Weingartl HM et al. Transmission of Ebola virus from pigs to non-human primates. Scientific Reports 2 (2012), Article number: 811 doi:10.1038/srep00811
COMMENT ON:
Are we *sure* Ebola isn’t airborne?
-----------------------------------------------------------
Sigue este Blog en Facebook y Twitter
viernes, 16 de mayo de 2014
Fitting Characteristics of #N95 Filtering-Facepiece #Respirators Used Widely in China
REFERENCE:
Yu et al. Fitting Characteristics of N95 Filtering-Facepiece Respirators Used Widely in China. PLoS One. 2014; 9(1): e85299.
--------------------------------------------
Sigue este Blog en Facebook y Twitter.
lunes, 28 de abril de 2014
Development and Performance Evaluation of an Exhaled-Breath #Bioaerosol Collector for #Influenza Virus
The importance of the aerosol mode for transmission of influenza is unknown. Understanding the role of aerosols is essential to developing public health interventions such as the use of surgical masks as a source control to prevent the release of infectious aerosols. Little information is available on the number and size of particles generated by infected persons, which is partly due to the limitations of conventional air samplers, which do not efficiently capture fine particles or maintain microorganism viability. We designed and built a new sampler, called the G-II, that collects exhaled breath particles that can be used in infectivity analyses. The G-II allows test subjects to perform various respiratory maneuvers (i.e. tidal breathing, coughing, and talking) and allows subjects to wear a mask or respirator during testing. A conventional slit impactor collects particles > 5.0 μm. Condensation of water vapor is used to grow remaining particles, including fine particles, to a size large enough to be efficiently collected by a 1.0 μm slit impactor and be deposited into a buffer-containing collector. We evaluated the G-II for fine particle collection efficiency with inert particle aerosols and evaluated infective virus collection using influenza A virus aerosols. Testing results showed greater than 85% collection efficiency for particles greater than 50nm and influenza virus collection comparable with a reference SKC BioSampler®. The new design will enable determination of exhaled infectious virus generation rate and evaluate control strategies such as wearing a surgical type mask to prevent the release of viruses from infected persons.
REFERENCE:
McDevitt JJ, Koutrakis P, Ferguson ST, et al. Development and Performance Evaluation of an Exhaled-Breath Bioaerosol Collector for Influenza Virus. Aerosol Sci Technol. 2013 January 1; 47(4): 444–451.
miércoles, 2 de abril de 2014
Exposure of Laboratory Animal Care Workers to Airborne Mouse and Rat Allergens
Urine of rats and mice is the main source of allergenic proteins that can enter the respiratory tract of laboratory animal care workers. Little is known about the levels and determinants of these exposures in the United States. We investigated the relationship between activities in animal facilities and levels of personal exposure to allergen by collecting personal breathing zone dust samples from 7 caretakers during full workdays for 1 wk. Mice and rat urinary allergens in inhalable dust were quantified via immunoassay. The activities of the sampled workers were observed, and the methods of preventing exposure to allergens were recorded. Mouse urinary allergen was detected in 20 of 39 measurements, yielding a geometric mean of 0.8 ng/m(3) with a maximum of 24 ng/m(3). Washing and cleaning cages and the number of mice handled daily were the most important determinants of personal exposure to mouse urinary allergen, as identified by using multiple linear regressions that explained 51% of total variance. Personal exposures to mouse urinary allergen were associated with day-to-day variation of tasks rather than characteristics of workers. Where potential for personal exposure is the highest, protective measures (N95 masks and cage dumping stations) appeared to be used, as is appropriate. Rat urinary allergen was detected in 4 of 39 measurements; detectable concentrations were between 0.8 and 39 ng/m(3). Only persons who handled rats were exposed to rat urinary allergen. The current findings are valuable for establishing exposure levels against which comparisons of improvement or deterioration of personal exposures can be made.
REFERENCE:
Glueck JT, Huneke RB, Perez H, Burstyn I. Exposure of laboratory animal care workers to airborne mouse and rat allergens. J Am Assoc Lab Anim Sci. 2012;51(5):554-60.
lunes, 24 de marzo de 2014
Exhaled Air Dispersion during Coughing #N95
Objectives: We compared the expelled air dispersion distances during coughing from a human patient simulator (HPS) lying
at 45u with and without wearing a surgical mask or N95 mask in a negative pressure isolation room.Methods: Airflow was marked with intrapulmonary smoke. Coughing bouts were generated by short bursts of oxygen flow at 650, 320, and 220L/min to simulate normal, mild and poor coughing efforts, respectively. The coughing jet was revealed by laser light-sheet and images were captured by high definition video. Smoke concentration in the plume was estimated from the light scattered by smoke particles. Significant exposure was arbitrarily defined where there was $ 20% of normalized smoke concentration.
Results: During normal cough, expelled air dispersion distances were 68, 30 and 15 cm along the median sagittal plane when the HPS wore no mask, a surgical mask and a N95 mask, respectively. In moderate lung injury, the corresponding air dispersion distances for mild coughing efforts were reduced to 55, 27 and 14 cm, respectively, p , 0.001. The distances were reduced to 30, 24 and 12 cm, respectively during poor coughing effort as in severe lung injury. Lateral dispersion distances during normal cough were 0, 28 and 15 cm when the HPS wore no mask, a surgical mask and a N95 mask, respectively.
Conclusions: Normal cough produced a turbulent jet about 0.7 m towards the end of the bed from the recumbent subject. N95 mask was more effective than surgical mask in preventing expelled air leakage during coughing but there was still significant sideway leakage.
Reference
martes, 18 de marzo de 2014
Nueva página de #Facebook para el Blog!
Buen Día..
lunes, 17 de marzo de 2014
Availability, consistency and evidence-base of policies and guidelines on the use of mask and respirator
Background: Currently there is an ongoing debate and limited evidence on the use of masks and respirators for the prevention of respiratory infections in health care workers (HCWs). This study aimed to examine available policies and guidelines around the use of masks and respirators in HCWs and to describe areas of consistency between guidelines, as well as gaps in the recommendations, with reference to the WHO and the CDC guidelines.Methods: Policies and guidelines related to mask and respirator use for the prevention of influenza, SARS and TB were examined. Guidelines from the World Health Organization (WHO), the Center for Disease Control and Prevention (CDC), three high-income countries and six low/middle-income countries were selected.
Results: Uniform recommendations are made by the WHO and the CDC in regards to protecting HCWs against seasonal influenza (a mask for low risk situations and a respirator for high risk situations) and TB (use of a respirator). However, for pandemic influenza and SARS, the WHO recommends mask use in low risk and respirators in high risk situations, whereas, the CDC recommends respirators in both low and high risk situations. Amongst the nine countries reviewed, there are variations in the recommendations for all three diseases. While, some countries align with the WHO recommendations, others align with those made by the CDC. The choice of respirator and the level of filtering ability vary amongst the guidelines and the different diseases. Lastly, none of the policies discuss reuse, extended use or the use of cloth masks.
Conclusion: Currently, there are significant variations in the policies and recommendations around mask and respirator use for protection against influenza, SARS and TB. These differences may reflect the scarcity of level-one evidence available to inform policy development. The lack of any guidelines on the use of cloth masks, despite widespread use in many low and middle-income countries, remains a policy gap. Health organizations and countries should jointly evaluate the available evidence, prioritize research to inform evidence gaps, and develop consistent policy on masks and respirator use in the health care setting.
Reference
Abrar Ahmad Chughtai, Holly Seale, Chandini Raina MacIntyre. Availability, consistency and evidence-base of policies and guidelines on the use of mask and respirator to protect hospital health care workers: a global analysis. BMC Res Notes. 2013; 6: 216.
miércoles, 12 de marzo de 2014
New Antimicrobial Surgical Glove
Background: Perforations of surgical gloves are common and increase with the duration of glove wear. Skin flora, re-grown after pre-operative disinfection of the hands, may contaminate a surgical site. An antimicrobial surgical glove with chlorhexidine on its inner surface has been developed. We hypothesized that by suppressing the re-growth of skin flora during the complete course of a surgical procedure, antimicrobial gloves may reduce the risk of surgical site contamination in the event of an intra-operative glove breach.
Methods: We conducted a randomized, double-blind, single-center trial, to measure any differences in the bacterial skin populations of surgeons' hands during surgical procedures done with antimicrobial and non-antimicrobial surgical gloves [ISRCTN71391952]. In this study, 25 pairs of gloves were retrieved from 14 surgeons who donned them randomly on their dominant or non-dominant hand. The number of bacteria retrieved from glove fluid was measured and expressed as colony forming units (CFU)/mL.
Results: The median cfu/mL of antimicrobial gloves was 0.00 (LQ: 0.00 CFU/mL; UQ: 0.00 cfu/mL), with a mean log10 cfu/mL=0.02 (range: 0.00–0.30). The median CFU/mL of non-antimicrobial gloves was 54.00 (LQ: 3.00 cfu/mL; UQ: 100.00 cfu/mL) with a mean log10 CFU/mL=1.32 (range: 0.00–2.39). After a mean operating time of 112 min, the difference in the log10 CFU/mL was 1.30 (p<0.001).
Conclusions: A new antimicrobial surgical glove suppressed surgeons' hand flora during operative procedures. In the event of a glove breach, the use of such a glove may have the potential to prevent bacterial contamination of a sterile surgical site, thereby decreasing the risk of surgical site infection (SSI) and increasing patient safety. Further clinical studies are needed to confirm this concept.
Reference
Assadian O, Kramer A, Ouriel K et al. Suppression of Surgeons' Bacterial Hand Flora during Surgical Procedures with a New Antimicrobial Surgical Glove. Surg Infect (Larchmt). Feb 1, 2014; 15(1): 43–49.
viernes, 31 de enero de 2014
#VIDEOS: Toma de muestras para diagnóstico de #influenza #EPP #Transporte
TOMA DE MUESTRAS NASOFARÍNGEAS
Curso: Capacitación en prevención de infecciones respiratorias #Influenza
Los módulos de capacitación están divididos en 6 presentaciones, complementarias más independientes. Se espera que el comité de control de infecciones o equipo responsable por educación del personal en salud utilicen estas presentaciones para la actualización del personal de salud y comunidad en el tema de medidas de prevención y control de infecciones con enfoque en las enfermedades respiratorias.
Se sugiere también que antes y después de la capacitación los participantes sean evaluados con la "Evaluación de la capacitación" para que se pueda saber cuál es el impacto de la capacitación en el conocimiento del personal de salud sobre el tema.
REFERENCIA:
Curso: Capacitación en prevención de infecciones en los servicios de salud con enfoque en las enfermedades respiratorias
viernes, 11 de octubre de 2013
Fire Exposures of Fire Fighter Self-Contained Breathing Apparatus Facepiece Lenses
REFERENCE
Fire Exposures of Fire Fighter Self-Contained Breathing Apparatus Facepiece Lenses
National Institute of Standards and Technology Technical Note 1724
Natl. Inst. Stand. Technol. Tech. Note 1724, 45 pages (November 2011)
CODEN: NSPUE2















